Uni- & Multivariable Analysis | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
Mortality (p-value from Pearson Chi2testing) | CD 3 to 5 (p-value from Pearson Chi2testing) | CD 1 to 5 (p-value from Pearson Chi2testing) | Mortality HR (95%CI; p) | CD 3 to 5 HR (95%CI; p) | CD 1 to 5 HR (95%CI; p) | |
Gender | 0.39 | 0.58 | 0.65 | Â | Â | Â |
Smoker | 0.98 | 0.49 | 0.74 | Â | Â | Â |
ECOG | 0.16 | 0.78 | 0.19 | 0.64 (0.36 to 1.13; p = 0.12) |  | 0.97 (0.83 to 1.12; p = 0.63) |
Anemia | 1.0 | 0.01 | 0.33 |  | 1.13 (0.80 to 1.57; p = 0.49) |  |
Sarcopenia | 0.91 | 0.14 | 0.01 |  |  | 1.70 (0.94 to 3.10; p = 0.08) |
HR changing medication | 0.81 | 0.62 | 0.77 | Â | Â | Â |
Protein-enriched drinks | 0.45 | 0.57 | 0.93 | Â | Â | Â |
Malignant disease | 0.13 | 0.02 | 0.08 | 1.13 (0.55 to 2.06; p = 0.84) | 1.14 (0.58 to 2.21; p = 0.70) | 1.07 (0.54 to 2.08; p = 0.84) |
Medical specialty | 0.85 | 0.27 | 0.17 |  |  | 0.97 (0.83 to 1.12; p = 0.63) |
Type of procedure | 0.50 | 0.004 | 0.002 |  | 1.0 (0.99 to 1.01; p = 0.21) | 1.00 (0.99 to 1.01; p = 0.34) |
RAI score | < 0.001 | 0.02 | 0.20 | 3.45 (0.39 to 30.3; p = 0.26) | 1.01 (0.61 to 1.93; p = 0.79) | 1.11 (0.64 to 1.94; p = 0.70) |
TUG | < 0.001 | 0.009 | 0.75 | 8.28 (0.82 to 84.1; p = 0.07) | 1.01 (0.58 to 1.79; p = 0.17) |  |
High-risk patient | 0.04 | 0.001 | 0.38 | 1.66 (0.09 to 30.3; p = 0.73) | 0.77 (0.37 to 1.59; p = 0.48) | 1.01 (0.69 to 1.46; p = 0.96) |
Weight loss | 0.81 | 0.002 | 002 |  | 1.29 (0.89 to 1.88; p = 0.17) | 1.24 (0.84 to 1.82; p = 0.27) |
Renal failure | 0.59 | 0.97 | 0.73 | Â | Â | Â |
Cardiac failure | 0.59 | 0.83 | 0.91 | Â | Â | Â |
Inappetence | 0.15 | 0.69 | 0.21 | 1.29 (0.79 to 2.12; p = 0.31) |  |  |
Shortness of breath | 0.83 | 0.35 | 0.77 | Â | Â | Â |
ADL mobility | 0.009 | 0.38 | 0.68 | 1.72 (0.21 to 13.9; p = 0.61) |  |  |
ADL eat | 0.99 | 0.62 | 0.93 | Â | Â | Â |
ADL toilet | < 0.001 | 0.56 | 0.86 | 0.53 (0.07 to 13.9; p = 0.61) |  |  |
Cognitive decline within three months before surgery | 0.53 | 0.32 | 0.76 | Â | Â | Â |